| Literature DB >> 35341404 |
Jessica Beck1, Ling Ren1, Shan Huang1, Erika Berger1, Kathleen Bardales1,2, Joshua Mannheimer1, Christina Mazcko1, Amy LeBlanc1.
Abstract
Osteosarcoma (OS) is the most common malignant bone tumor in children. Despite efforts to develop and implement new therapies, patient outcomes have not measurably improved since the 1980s. Metastasis continues to be the main source of patient mortality, with 30% of cases developing metastatic disease within 5 years of diagnosis. Research models are critical in the advancement of cancer research and include a variety of species. For example, xenograft and patient-derived xenograft (PDX) mouse models provide opportunities to study human tumor cells in vivo while transgenic models have offered significant insight into the molecular mechanisms underlying OS development. A growing recognition of naturally occurring cancers in companion species has led to new insights into how veterinary patients can contribute to studies of cancer biology and drug development. The study of canine cases, including the use of diagnostic tissue archives and clinical trials, offers a potential mechanism to further canine and human cancer research. Advancement in the field of OS research requires continued development and appropriate use of animal models. In this review, animal models of OS are described with a focus on the mouse and tumor-bearing pet dog as parallel and complementary models of human OS.Entities:
Keywords: canine; comparative oncology; dogs; experimental animal models; metastasis; mice; murine models; osteosarcoma; review; veterinary clinical trials
Mesh:
Year: 2022 PMID: 35341404 PMCID: PMC9290378 DOI: 10.1177/03009858221083038
Source DB: PubMed Journal: Vet Pathol ISSN: 0300-9858 Impact factor: 3.157